25 Jul
Anti-soluble liver antigen antibodies are detected in 10-30% of patients with type 1 autoimmune hepatitis (AIH). It is not detect-
ed in patients with type 2 AIH, primary sclerosing cholangitis or primary biliary cirrhosis. This antibody is directed against a
UGA suppressor tRNA associated protein. In certain AIH patients, this antibody may be the only autoantibody detected by currently available assays.